LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy

Photo by docvk03 from unsplash

Simple Summary Collecting appropriate gastric cancer (GC) tissues is critical for molecular biology research or the development of new target drugs for cases resistant to chemotherapy. Chemotherapy may reduce or… Click to show full abstract

Simple Summary Collecting appropriate gastric cancer (GC) tissues is critical for molecular biology research or the development of new target drugs for cases resistant to chemotherapy. Chemotherapy may reduce or alter the distribution of GC tissue on the surface, making the detection of GC tissue during upper endoscopy challenging. Our study showed that probe-based confocal laser endomicroscopy (pCLE) is superior to white-light endoscopy (WLE) with magnifying narrow-band imaging (M-NBI) in terms of accuracy for diagnosing residual cancer in GC patients receiving chemotherapy. pCLE might be considered when it is necessary to confirm the presence of residual cancer and get tissue samples from GC patients receiving chemotherapy. Abstract In cases of progression despite chemotherapy, collecting gastric cancer (GC) tissues might be helpful for molecular biology research or the development of new target drugs for treating cases that are refractory to chemotherapy. Chemotherapy, however, may reduce or alter the distribution of GC tissue on the surface, making the detection of GC tissue during upper endoscopy challenging. Probe-based confocal laser endomicroscopy (pCLE) is a new technology that enables histological diagnosis by magnifying the mucous membrane to a microscopic level. Here, we evaluated whether pCLE could increase the yield of endoscopic biopsy for GC compared to white-light endoscopy (WLE) with magnifying narrow-band imaging (M-NBI) in GC patients receiving chemotherapy with its powerful imaging technique. Patients underwent WLE/M-NBI and pCLE for the detection of residual GC for the purpose of response evaluation or clinical trial registration. After WLE/M-NBI and pCLE, each residual GC lesion was biopsied for histological analysis. A total of 23 patients were enrolled between January 2018 and June 2020. Overall, pCLE showed significantly higher sensitivity and negative predictive value than WLE/M-NBI. The accuracy of pCLE was superior to that of WLE/M-NBI. Moreover, pCLE showed better predictive ability for residual GC than WLE/M-NBI, while WLE/M-NBI and pCLE showed inconsistent results. pCLE diagnosed residual GC more accurately than WLE/M-NBI, which resulted in an increased number of GC tissues collected during the endoscopic biopsy.

Keywords: endoscopy; wle nbi; pcle; chemotherapy; cancer; tissue

Journal Title: Cancers
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.